Skip to content

Clinical trials

Recruiting Breast Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Recruiting Country / region: United Kingdom Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20181
20193
20202
20212
20226
202314
202411
202523
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
AstraZeneca4
Merck Sharp & Dohme LLC4
Royal Marsden NHS Foundation Trust4
University Hospitals of Derby and Burton NHS Foundation Trust3
BioNTech SE2
Bristol-Myers Squibb2
Cambridge University Hospitals NHS Foundation Trust2
Imperial College London2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms71
Triple Negative Breast Neoplasms9
Neoplasm Metastasis8
Ovarian Neoplasms7
Prostatic Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Neoplasms5
Pancreatic Neoplasms5
Brain Neoplasms4
Endometrial Neoplasms4

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.